**IMPORTANT REMINDER** The Standard Registration Deadline for CINP 2026 is fast approaching and will close on 9 June 2026. If you are planning to attend CINP 2026 in Glasgow, now is the time to secure your registration. Don't leave it until the last minute! Complete your registration today and ensure your place among colleagues from across the global neuropsychopharmacology community.
|
We are pleased to congratulate the newly elected officers and councillors, who will officially assume their roles during the CINP 2026 Congress.
We warmly congratulate all those elected and look forward to their leadership and contributions to the global CINP community in the years ahead. We would also like to sincerely thank all candidates who stood in this election for their commitment, engagement, and willingness to serve CINP and the field of neuropsychopharmacology. |
Planning your trip to Glasgow for CINP 2026? We would encourage you to arrange your accommodation as early as possible. The city will be particularly busy during the congress dates, with several major concerts and events taking place at the same time, and hotel availability is already becoming limited. We look forward to welcoming our community to Glasgow and want to ensure your stay is as smooth and comfortable as possible. You are welcome to check the available rooms on the congress website. Book early to secure your preferred option! |
Follow CINP on Social Media Stay connected with the latest news, research highlights, events, and updates from CINP. Join our growing global community across social media: Facebook: X (Twitter): Instagram: LinkedIn: https://www.linkedin.com/company/international-college-of-neuropsychopharmacology/ YouTube: Follow us to stay informed, engage with the community, and be part of the conversation shaping the future of neuropsychopharmacology. |
We are excited to announce the recipients of the Rafaelsen Young Investigators Award 2026:
Due to a very high number of entries of exceptional quality, the following applicants have been awarded a President's Recognition for Young Investigators diploma:
Congratulations to all awardees! |
We are pleased to share a new Genomic Press Interview with Dr. Gabriella Gobbi, CINP President Elect, Professor of Psychiatry at McGill University, and Canada Research Chair in Therapeutics for Mental Health. From pioneering research on adolescent cannabis exposure and depression, to advancing novel melatonin receptor therapeutics, and early work on the neurobiology of psychedelics - Dr. Gobbi’s career exemplifies truly translational science. As the first woman elected CINP President in its 70-year history, she reflects on her journey from Italy to Canada, the clinical insights that shaped her research, and her vision for a neuropsychopharmacology that remains deeply connected to patient care. |
GLOBAL
| International Journal of Neuropsychopharmacology
Impact Factor: 3.7 |
-
March 20, 2026 06:20
-
January 30, 2026 10:48
-
December 17, 2025 15:46
